BACKGROUND: Many studies have evaluated the association between vitamin and mineral supplement use and the risk of prostate cancer, with inconclusive results. METHODS: The authors examined the relation of use of multivitamins as well as several single vitamin and mineral supplements to the risk of prostate cancer risk among 1,706 prostate cancer cases and 2,404 matched controls using data from the hospital-based case-control surveillance study conducted in the United States. Odds ratios (OR) and 95% confidence intervals (CI) for risk of prostate cancer were estimated using conditional logistic regression model. RESULTS: For use of multivitamins that did not contain zinc, the multivariable odds ratios of prostate cancer were 0.6 for 1-4 years, 0.8 for 5-9 years, and 1.2 for 10 years or more, respectively (p for trend = 0.70). Men who used zinc for ten years or more, either in a multivitamin or as a supplement, had an approximately two-fold (OR = 1.9, 95% CI: 1.0, 3.6) increased risk of prostate cancer. Vitamin E, beta-carotene, folate, and selenium use were not significantly associated with increased risk of prostate cancer. CONCLUSION: The finding that long-term zinc intake from multivitamins or single supplements was associated with a doubling in risk of prostate cancer adds to the growing evidence for an unfavorable effect of zinc on prostate cancer carcinogenesis.
BACKGROUND: Many studies have evaluated the association between vitamin and mineral supplement use and the risk of prostate cancer, with inconclusive results. METHODS: The authors examined the relation of use of multivitamins as well as several single vitamin and mineral supplements to the risk of prostate cancer risk among 1,706 prostate cancer cases and 2,404 matched controls using data from the hospital-based case-control surveillance study conducted in the United States. Odds ratios (OR) and 95% confidence intervals (CI) for risk of prostate cancer were estimated using conditional logistic regression model. RESULTS: For use of multivitamins that did not contain zinc, the multivariable odds ratios of prostate cancer were 0.6 for 1-4 years, 0.8 for 5-9 years, and 1.2 for 10 years or more, respectively (p for trend = 0.70). Men who used zinc for ten years or more, either in a multivitamin or as a supplement, had an approximately two-fold (OR = 1.9, 95% CI: 1.0, 3.6) increased risk of prostate cancer. Vitamin E, beta-carotene, folate, and selenium use were not significantly associated with increased risk of prostate cancer. CONCLUSION: The finding that long-term zinc intake from multivitamins or single supplements was associated with a doubling in risk of prostate cancer adds to the growing evidence for an unfavorable effect of zinc on prostate cancer carcinogenesis.
Authors: J Kellogg Parsons; H Ballentine Carter; Elizabeth A Platz; E James Wright; Patricia Landis; E Jeffrey Metter Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-09 Impact factor: 4.254
Authors: T J Hartman; D Albanes; P Pietinen; A M Hartman; M Rautalahti; J A Tangrea; P R Taylor Journal: Cancer Epidemiol Biomarkers Prev Date: 1998-04 Impact factor: 4.254
Authors: Victoria L Stevens; Marjorie L McCullough; W Ryan Diver; Carmen Rodriguez; Eric J Jacobs; Michael J Thun; Eugenia E Calle Journal: Cancer Causes Control Date: 2005-08 Impact factor: 2.506
Authors: Stephanie J Weinstein; Margaret E Wright; Pirjo Pietinen; Irena King; Carly Tan; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes Journal: J Natl Cancer Inst Date: 2005-03-02 Impact factor: 13.506
Authors: Victoria A Kirsh; Richard B Hayes; Susan T Mayne; Nilanjan Chatterjee; Amy F Subar; L Beth Dixon; Demetrius Albanes; Gerald L Andriole; Donald A Urban; Ulrike Peters Journal: J Natl Cancer Inst Date: 2006-02-15 Impact factor: 13.506
Authors: J Michael Gaziano; Howard D Sesso; William G Christen; Vadim Bubes; Joanne P Smith; Jean MacFadyen; Miriam Schvartz; JoAnn E Manson; Robert J Glynn; Julie E Buring Journal: JAMA Date: 2012-11-14 Impact factor: 56.272
Authors: Marilyn L Kwan; Heather Greenlee; Valerie S Lee; Adrienne Castillo; Erica P Gunderson; Laurel A Habel; Lawrence H Kushi; Carol Sweeney; Emily K Tam; Bette J Caan Journal: Breast Cancer Res Treat Date: 2011-05-11 Impact factor: 4.872